PATENT LICENCE AGREEMENT (ADAIR PATENT RIGHTS) (MEDI-493) between CELLTECH THERAPEUTICS LIMITED and MEDIMMUNE INC.Patent License Agreement • July 21st, 2005 • Medimmune Inc /De • Biological products, (no disgnostic substances)
PATENT LICENCE (ADAIR PATENT RIGHTS) (MEDI-493) VARIATION AGREEMENTPatent License Agreement • July 21st, 2005 • Medimmune Inc /De • Biological products, (no disgnostic substances)
THIS VARIATION AGREEMENT entered into this 24th day of June 2005 by and between CELLTECH R&D LIMITED (registered in England No. 1472269) whose principal place of business is at 208 Bath Road, Slough, Berkshire, SL1 3WE, England (“Celltech”) and UCB S.A. (Register of Commerce No. 85.078/Company No. 0403 053 608) whose registered office is at 60 Allee de la Recherche, B-1070 Brussels, Belgium and whose UK branch is registered in England (registered No. BR007969) and situate at 208 Bath Road, Slough, Berkshire, SL1 3WE (“UCB”) and MEDIMMUNE, INC., a company incorporated under the laws of the state of Delaware, United States of America, having its principal place of business at One MedImmune Way, Gaithersburg, MD 20878 (“Licensee”).
